(ABVC) ABVC Biopharma - Performance 320.3% in 12m
ABVC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-63.70%
#90 in Peer-Group
Rel. Strength
98.70%
#101 in Stock-Universe
Total Return 12m
320.27%
#2 in Peer-Group
Total Return 5y
-88.04%
#108 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.11 USD |
| 52 Week Low | 0.42 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 97.77 |
| Buy/Sell Signal +-5 | 1.43 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ABVC (320.3%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ABVC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABVC
| Total Return (including Dividends) | ABVC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 96.84% | 3.36% | 5.25% |
| 3 Months | 319.14% | 15.73% | 24.13% |
| 12 Months | 320.27% | -7.02% | 14.15% |
| 5 Years | -88.04% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ABVC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 96.9% | 4.4% | 81% |
| 3 Months | 95.6% | 78.8% | 96.9% |
| 12 Months | 40.4% | -85.8% | 44.9% |
| 5 Years | -94% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th98.50 | 90.45% | 87.02% |
| 3 Month | %th99.00 | 262.17% | 237.66% |
| 12 Month | %th99.50 | 352.02% | 268.16% |
| 5 Years | %th47.00 | -83.68% | -94.37% |
FAQs
Does ABVC Biopharma (ABVC) outperform the market?
Yes,
over the last 12 months ABVC made 320.27%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ABVC made 319.14%, while XBI made 15.73%.
Performance Comparison ABVC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ABVC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 18.4% | 91.6% | 350.9% | 306% |
| US NASDAQ 100 | QQQ | 18.6% | 91.5% | 350.2% | 308% |
| German DAX 40 | DAX | 20.5% | 98.3% | 338.7% | 291% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 18.5% | 93.6% | 347.5% | 300% |
| Hongkong Hang Seng | HSI | 18.8% | 90.8% | 331.4% | 282% |
| India NIFTY 50 | INDA | 20.2% | 93.4% | 350.6% | 321% |
| Brasil Bovespa | EWZ | 15.9% | 88% | 325.8% | 310% |
ABVC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 19.8% | 90.9% | 346.8% | 296% |
| Consumer Discretionary | XLY | 18.9% | 93.7% | 358.5% | 302% |
| Consumer Staples | XLP | 18.1% | 96.2% | 349.2% | 311% |
| Energy | XLE | 18.1% | 89.8% | 355% | 320% |
| Financial | XLF | 17.7% | 91.8% | 346% | 290% |
| Health Care | XLV | 18.9% | 94.7% | 358.2% | 325% |
| Industrial | XLI | 18.3% | 92.6% | 343% | 295% |
| Materials | XLB | 16.1% | 92.6% | 346.4% | 314% |
| Real Estate | XLRE | 18.4% | 95.9% | 351.2% | 307% |
| Technology | XLK | 17.6% | 88.2% | 348.6% | 309% |
| Utilities | XLU | 19.5% | 95.1% | 347.7% | 297% |
| Aerospace & Defense | XAR | 20.5% | 89.8% | 332.3% | 271% |
| Biotech | XBI | 17.4% | 93.5% | 364.1% | 327% |
| Homebuilder | XHB | 15.9% | 89.8% | 358.1% | 315% |
| Retail | XRT | 15.8% | 91.9% | 355.2% | 309% |
ABVC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 17.5% | 88.4% | 359% | 328% |
| Natural Gas | UNG | 27.9% | 106.7% | 367.7% | 323% |
| Gold | GLD | 18.1% | 98.1% | 330.3% | 281% |
| Silver | SLV | 17.4% | 89.9% | 333.5% | 303% |
| Copper | CPER | 19.3% | 92.3% | 333.8% | 309% |
ABVC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 20.2% | 95.8% | 354.3% | 322% |
| iShares High Yield Corp. Bond | HYG | 19.6% | 95.2% | 352% | 310% |